These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9001917)

  • 1. Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide and melphalan.
    Hansel S; Castegnaro M; Sportouch MH; De Méo M; Milhavet JC; Laget M; Duménil G
    Int Arch Occup Environ Health; 1997; 69(2):109-14. PubMed ID: 9001917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical degradation of wastes of antineoplastic agents. 2: Six anthracyclines: idarubicin, doxorubicin, epirubicin, pirarubicin, aclarubicin, and daunorubicin.
    Castegnaro M; De Méo M; Laget M; Michelon J; Garren L; Sportouch MH; Hansel S
    Int Arch Occup Environ Health; 1997; 70(6):378-84. PubMed ID: 9439983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical degradation of wastes of antineoplastic agents amsacrine, azathioprine, asparaginase and thiotepa.
    Barek J; Cvacka J; de Méo M; Laget M; Michelon J; Castegnaro M
    Ann Occup Hyg; 1998 May; 42(4):259-66. PubMed ID: 9713249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safe decontamination of cytostatics from the nitrogen mustards family. Part one: cyclophosphamide and ifosfamide.
    Štenglová Netíková IR; Petruželka L; Šťastný M; Štengl V
    Int J Nanomedicine; 2018; 13():7971-7985. PubMed ID: 30538471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecotoxicity and genotoxicity of cyclophosphamide, ifosfamide, their metabolites/transformation products and their mixtures.
    Česen M; Eleršek T; Novak M; Žegura B; Kosjek T; Filipič M; Heath E
    Environ Pollut; 2016 Mar; 210():192-201. PubMed ID: 26735164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation and inactivation of antitumor drugs.
    Benvenuto JA; Connor TH; Monteith DK; Laidlaw JL; Adams SC; Matney TS; Theiss JC
    J Pharm Sci; 1993 Oct; 82(10):988-91. PubMed ID: 8254498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water.
    Kümmerer K; Al-Ahmad A
    Environ Sci Pollut Res Int; 2010 Feb; 17(2):486-96. PubMed ID: 19548016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photocatalytic degradation of cyclophosphamide and ifosfamide: Effects of wastewater matrix, transformation products and in silico toxicity prediction.
    A Osawa R; T Barrocas B; C Monteiro O; Oliveira MC; Florêncio MH
    Sci Total Environ; 2019 Nov; 692():503-510. PubMed ID: 31351292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility of palonosetron with cyclophosphamide and with ifosfamide during simulated Y-site administration.
    Xu QA; Trissel LA
    Am J Health Syst Pharm; 2005 Oct; 62(19):1998-2000. PubMed ID: 16174835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures for destruction of patulin in laboratory wastes.
    Frémy JM; Castegnaro MJ; Gleizes E; De Meo M; Laget M
    Food Addit Contam; 1995; 12(3):331-6. PubMed ID: 7664923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation and disposal of some antineoplastic drugs.
    Lunn G; Sansone EB; Andrews AW; Hellwig LC
    J Pharm Sci; 1989 Aug; 78(8):652-9. PubMed ID: 2550609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide versus ifosfamide: to use ifosfamide or not to use, that is the three-dimensional question.
    Williams ML; Wainer IW
    Curr Pharm Des; 1999 Aug; 5(8):665-72. PubMed ID: 10469897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the control of mutagenic metabolites derived from cyclophosphamide and ifosfamide by stimulation of protein kinase A.
    Oesch-Bartlomowicz B; Vogel S; Arens HJ; Oesch F
    Mutat Res; 1990 Oct; 232(2):305-12. PubMed ID: 2170835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters.
    Buerge IJ; Buser HR; Poiger T; Müller MD
    Environ Sci Technol; 2006 Dec; 40(23):7242-50. PubMed ID: 17180973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The leaching behavior of cyclophosphamide and ifosfamide from soil in the presence of co-contaminant--Mixture sorption approach.
    Mioduszewska K; Maszkowska J; Białk-Bielińska A; Krüger O; Kalbe U; Liberek B; Łukaszewicz P; Stepnowski P
    Sci Total Environ; 2016 Jan; 542(Pt A):915-22. PubMed ID: 26562339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test.
    Benedict WF; Baker MS; Haroun L; Choi E; Ames BN
    Cancer Res; 1977 Jul; 37(7 Pt 1):2209-13. PubMed ID: 193638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the Use of Ozone Water as a Chemical Decontamination Agent for Antineoplastic Drugs in Clinical Settings.
    Kato G; Mitome H; Teshima K; Tawa K; Hakuba Y; Tanabe T; Funahashi T; Hatae N; Koike Y; Hasebe M; Hidaka N; Tanaka M; Akira K
    Ann Work Expo Health; 2023 Feb; 67(2):241-251. PubMed ID: 36416483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial measurements of ifosfamide and cyclophosphamide in patients using (31)P MRS: pulse-and-acquire, decoupling, and polarization transfer.
    Payne GS; Pinkerton CR; Bouffet E; Leach MO
    Magn Reson Med; 2000 Aug; 44(2):180-4. PubMed ID: 10918315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fenton technique for oxidation treatment of solid-waste containing aniline].
    Hu LF; Yao J; Lou B; He R; Shen DS
    Huan Jing Ke Xue; 2008 Jan; 29(1):104-8. PubMed ID: 18441925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological degradation of cyclophosphamide and its occurrence in sewage water.
    Steger-Hartmann T; Kümmerer K; Hartmann A
    Ecotoxicol Environ Saf; 1997 Mar; 36(2):174-9. PubMed ID: 9126435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.